SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " QT " 1,344 found 🔀 AI-powered Shuffle
University of Iowa Health Care calls off $2B+ patient tower build
Plans to build a new, $2 billion-plus patient care tower and other accompanying upgrades at the University of Iowa Health Care’s main campus are off the table in favor of smaller-scale upgrades to | "Significant financial challenges” facing the healthcare industry at large have limited Iowa Health Care’s ability to “responsibly” deploy capital toward the five-year build. It is now proposing a $380 million capital plan focused on updating and expanding existing facilities.
Deaconess Health System earns spot on Forbes 2026 employer list
Officials say this honor highlights Deaconess Health System’s ongoing commitment to fostering a workplace culture where employees feel supported, valued and empowered to make a difference.
Optum Health CEO pulls back curtain on turnaround
As UnitedHealth Group continues to chart its turnaround from a challenging 2025, the company's top brass is pulling back the curtain on those efforts at its healthcare services unit, Optum Health.< | As UnitedHealth Group continues to chart a turnaround from a challenging 2025, the company's top brass is pulling back the curtain on those efforts at its healthcare services unit, Optum Health.
iPhone 17 Pro vs. iPhone 18 Pro: 35+ Upgrades Compared
Apple yesterday announced the iPhone 18 Pro and iPhone 18 Pro Max, succeeding the iPhone 17 Pro that launched last September. The new models are built around the A20 Pro chip, a 48-megapixel Fusion Main camera with variable aperture, a redesigned vapor chamber, and a smaller Dynamic Island. Last year's iPhone 17 Pro brought one of the biggest design changes to the lineup in years, switching from a titanium frame and glass back to an aluminum unibody with Ceramic Shield 2.
Interra Health now supports CMS’ GLP-1 Bridge Program
Electronic prescribing platform Interra Health announced Tuesday that it now supports the U.S. | Interra Health’s platform alerts providers when patients may be eligible to enroll in the program, executives say.
Anomaly Insights, Inova Health partner on AI-powered RCM
Artificial intelligence-powered payer intelligence startup Anomaly Insights announced Thursday a collaboration with Inova Health to improve payment outcomes and support revenue management operation | Through the partnership, Anomaly will provide Inova with additional data and analytics to evaluate payer behavior and payment outcomes.
As elective surgical volumes drag in 2026, health system execs say solid demand is still in sight
Though surgical volumes were a sore spot for major for-profit health systems in the opening half of 2026, executives said this week they are optimistic those service lines will stay afloat for the | In fireside chats this week, leaders of the country's largest for-profit systems acknowledged a slowdown in demand that will generally continue through 2026. They also affirmed continued investments to meet future anticipated demand, particularly in ambulatory settings.
The hidden value of health in Asia-Pacific
Health expenditure is routinely counted. But the value health protects through work, income, independence and unpaid care is far less visible.
Obsidian Netron FS16 For Data-Intensive Entertainment Applications
Obsidian Control Systems is pleased to introduce the Netron FS16, a purpose-built network switch designed for lighting p | A purpose-built network switch designed for lighting professionals who demand rock-solid connectivity under the pressure of live production.
Polytech CEO after acquisition: “It strengthens our core business”
In addition to strengthening its core business, the acquisition of Dansk Gummi Industri opens up new opportunities for Polytech. The CEO does not rule out further acquisitions.
Children of 9/11 to finally get a major health study
By Nancy Lapid Sept 10 (Reuters) – When hijacked planes brought down the World Trade Center’s twin towers on September 11, 2001, roughly 25,000 children were living or attending school nearby in lower Manhattan, and thousands more were in surrounding neighborhoods. Some were infants and […]
Williamson County moves forward with plans to sell health system to Ascension St. Thomas
The Williamson County Commission voted to approve a non-binding letter of intent to sell Williamson Health to Ascension St. Thomas Wednesday night.
'Hope' review: Na Hong-jin's savage and smart monster movie is a must-see
Michael Fassbender? Alicia Vikander? What are you doing here?
Trump’s Census Overhaul Would Exclude Some Immigrants and Remove Questions on Race
The proposals for 2030 are among significant changes that would upend a process for helping allot congressional seats and shape policies that address disparities.
Bald Head Island Conservancy lands $424K grant for coastal science training
A Brunswick County conservation group is getting nearly half a million dollars in federal funding to expand hands-on coastal conservation training for dozens of local students.
W.Va. expands Medicaid school-based health services
The West Virginia Department of Human Services (DoHS) Bureau for Medical Services and the West Virginia Department of Education (WVDE) are partnering to expand school-based health services, giving more students statewide access to vital medical and mental healthcare.
Increases in healthcare spending the largest driver behind premium growth: Yale study
As insurance premiums continue to rise, a new study finds that escalating healthcare spending is the leading factor behind the trend. | As insurance premiums continue to rise, a new study finds that escalating healthcare spending is the leading factor behind the trend.
Luma locks down 15-year, $410M fund for life science investments
Luma Group today announced the final close of its inaugural life sciences venture capital fund, totaling $410 million. The New York-based investment firm has had a grip on life sciences since its founding in 2023. The funds unveiled today, dubbed LumaBio Fund I, include investments that have already been made into more than 10 biotechs. They include the likes of eye disease-focused Character Biosciences, rebranded Belgian biotech Coultreon Biopharma and cellular rejuvenation company Altos Labs. The fund saw early success when one of the companies it co-founded, called Vaccine Company, was picked up by Eli Lilly earlier this year for up to $1.55 billion. The acquisition of the in vivo nanoparticle technology-focused biotech formed part of a trio of vaccine buys for the Big Pharma, which has itself been on a prolonged spending spree in 2026. Luma's fund is structured as a 15-year investment with plans to support groundbreaking science and support companies through key milestones from discovery to commercialization, Luma explained in the release. "We founded Luma Group on the belief that extraordinary science, supported by patient, long-term capital, has the power to improve millions of lives," Joshua Fink, founder and managing member of Luma Group, said in the release. "This fund represents more than capital—it is a commitment to partnering with extraordinary innovators as they translate visionary science into life-changing medicines."
H1 acquires Defacto Health to expand provider network intelligence
H1 has acquired Defacto Health, a healthcare data company focused on provider network intelligence, in a move to expand its offerings for health plans and strengthen its healthcare data assets. | H1 has acquired Defacto Health, a healthcare data company focused on provider network intelligence, in a move to expand its offerings for health plans and strengthen its healthcare data assets.
Lubbock first responders promote wellness programs to address mental health
First responders in Lubbock are highlighting department wellness programs designed to give officers, firefighters and paramedics access to mental health support.
Senate Set to Vote to Begin Debate on Protect College Sports Act
Background The Protect College Sports Act of 2026 (PCSA), introduced in the Senate on June 2, 2026, by Senators Ted Cruz (R-TX) and Maria Cantwell (D-WA) and joined by Senators Eric Schmitt (R-MO) and Chris Coons (D-DE), represents a comprehensive federal legislative effort to reshape the governance and economics of intercollegiate athletics, including redistributing the significant media revenues generated by college sports. Reported favorably 19-9 from the Senate Commerce Committee and placed on Senate Calendar No. 449 on June 24, 2026, the PCSA was substantially revised on August 7, 2026 (Senate Amendment 6768). The PCSA arrives against a backdrop of cascading judicial decisions that have systematically dismantled the National Collegiate Athletic Association’s (NCAA) authority to regulate the economics of college sports.
Independent Kansas health systems launch shared services organization
Five Kansas health systems have launched a regional collaboration, called Astra Health, to pool resources and coordinate services while retaining their independence. | Astra Health's five founding members, who serve more than half a million patients annually, hope to improve quality and trim costs at scale while maintaining their independence.
More than 200 Jefferson Health nurses to vote on unionizing
Nurses held a rally outside Jefferson Bucks Hospital Tuesday.
TN health department rolls out grants through new rural healthcare program
The Rural Health Transformation Program awards grant money to innovative projects that strengthen healthcare access in remote parts of Tennessee.
Independent hospitals form partnership to strengethen Kansas healthcare
Five independent health systems banned together to create Astra Health, a collaboration seeking to strengthen healthcare in Kansas.
Lancaster County judge hears challenge to Nebraska K-12, collegiate sports ballot measure
A Lincoln voter refiled a challenge this week to a ballot measure seeking to cement limits on public school sports participation to student-athletes’ sex at birth after the Nebraska Supreme Court declined to hear the lawsuit.
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
With a detailed data drop that AstraZeneca’s R&D chief described as an internal “science success story,” the British Big Pharma has secured an FDA priority review for what it believes could become a flagship biologic in chronic obstructive pulmonary disease (COPD). In detailed results from the late-stage Oberon and Titania trials—first teased in March and detailed in full at the European Respiratory Society Congress in Barcelona this week—the drugmaker laid out the extent of its IL-33 inhibitor’s potential to reduce moderate and severe exacerbations in a wide range of COPD patients still struggling with those “lung attacks,” as AstraZeneca’s Sharon Barr, Ph.D., called them, despite using standard-care inhaled therapy. In the headline results, a 300 mg dose of tozorakimab given once every four weeks curbed those moderate and severe exacerbations in the studies’ primary population of former smokers by 29% in the Oberon study and 34% in Titania. In the overall population of both current and former smokers, these reductions were 30% and 29%, respectively, versus placebo and inhaled standard of care. The benefits also extended to clinically meaningful exacerbation reductions in all prespecified patient subgroups and specifically turned up promising signals in patients across a range of blood eosinophil counts, with Barr telling Fierce that “it’s the details that make this even more exciting than the high-level results that we’ve already shared.” In fact, during AZ’s tozorakimab poster presentation at the ERS 2026 Congress this past weekend, attendees were so enamored by the data that event organizers had to encourage people to clear the room and look at the other presentations on offer, Barr said in an interview. “I think it really speaks to the fact that there is a lot of buzz around these data because the entire respiratory community has been so desperate for new therapies for these patients,” she explained. The respiratory disease continues to represent a “staggering unmet medical need,” Barr said, highlighting the COPD exacerbations that the Oberon and Titania studies homed in on, which she added carry a greater mortality risk than a heart attack. “When a patient has a severe exacerbation, only about half of them are still alive within three and a half years,” she pointed out. As for tozorakimab specifically, Barr christened the molecule “an AstraZeneca science success story,” harkening several years back to the point at which researchers began to explore IL-33 as a driver of respiratory disease, and COPD in particular. At the same time, “there was still so much that wasn’t understood,” she admitted, highlighting the insight that IL-33 signals through both ST2 and EGFR through the RAGE pathway, a discovery Barr attributed to AstraZeneca's own scientists. Understanding the need to tackle both pathways in COPD—and aware of competitor candidates in the hopper, including one that bound ST2—the company ultimately had to make some “courageous decisions,” Barr said. These included taking a prior COPD molecule offline and going back to the drawing board to reinvent its potential IL-33 label “to make sure that we had a molecule that could block signaling through both arms of the pathway, through both the reduced form and the oxidized form, knowing that we wouldn’t be first, but striving to be best.” “When we put [tozorakimab] into the clinic, we firmly believed that we had a differentiated molecule, and we saw the other molecules blocking just ST2 or partially blocking IL-33, unable to deliver two positive pivotal studies in COPD,” Barr explained. “We kept marching forward because we believed our molecule was differentiated, and now I think we have the clinical validation that supports that.” Ultimately, AstraZeneca finds itself on much better footing these days when it comes to potential biologic rivals to tozorakimab in COPD. Sanofi and Regeneron’s Dupixent, for instance, is approved to treat COPD exacerbations in patients with high eosinophil counts, but not low ones. Meanwhile, the future has become cloudier for other next-gen IL-33 candidates from Sanofi and Regeneron, as well as Roche, which have suffered trial flops in recent years. One other potential ingredient for AstraZeneca’s success in its duo of studies was that the company was “ambitious in the trial design, willing to look at an all-comers population,” Barr said, “and willing to enroll the most severe patients.” Prior studies for would-be biologics rivals in COPD “avoided enrolling” those patients, she pointed out. She also highlighted the Big Pharma’s painstaking design of exacerbations in its trial, which “gave us a very rigorous readout,” and pointed to “the extra effort and investment” the company put in to understand the effect of mucus plugs in patients. Barr described mucus production as a “key feature in disease diversity,” noting that mucus plugs—obstructing clumps of mucus that block patients’ airways—are associated with worse outcomes in COPD. In its data announcement, AstraZeneca noted that an integrated analysis of Oberon and Titania found tozorakimab “demonstrated a reduction in patients’ mucus plug score,” with the pharma claiming its biologic is the first to deliver such results in a broad COPD population. “So being able to reduce those mucus plugs, we expect, is an important part of driving benefit for patients who are living with COPD,” Barr said. Again touching on the breadth of the study populations, Barr added that tozorakimab “worked across all eosinophil levels in both current and former smokers across all levels of lung function,” which she suggested “really simplifies decision-making for clinicians, and it allows them to offer therapy to the broadest possible patient population.” In the highest patient eosinophil count group, tozorakimab helped chart a 43% reduction in exacerbation risk, which Barr stressed were “unprecedented data.” In the mid-level group, AZ’s drug delivered a 23% reduction and, in the lowest group, a 34% reduction in eosinophils, which Barr said suggests efficacy “in all patient subgroups.” As for AZ’s recent guidance upgrade on the medicine’s sales opportunity, the lift from a $3 billion to $5 billion range to $5 billion plus was informed by multiple factors, Barr said, including the fact that “in 2024, there were multiple competitors, and there aren’t anymore.” Additionally, “we know that this is a massive unmet medical need, and this is a really incredible set of data that we think will be very convincing to the clinical community,” Barr said. Looking ahead to a potential evolution of the COPD treatment landscape, Barr noted that most patients start treatment in the community with an option like a triple therapy, and for them, having an option like AstraZeneca’s inhaler Breztri will remain a “really important part” of that journey. But of the patients uncontrolled on triple therapy, which Barr described as “about half of them today,” just a “small fraction” are currently eligible for biologic therapy, which she emphasized AstraZeneca is working to change. Understanding that COPD is not a “one-size-fits-all” disease, AstraZeneca is also looking at its antibody drug Tezspire for patients with T2-driven disease, and the company continues to think about new mechanisms for tackling COPD through both systemic and inhaled drugs, Barr said.
Parakeet Health lands major AI partnership with national dermatology group Qualderm
Parakeet Health landed a major partnership with Qualderm, one of the nation's largest dermatology organizations, as the company looks to apply agentic artificial intelligence to a growing specialty | Parakeet Health landed a major partnership with Qualderm, one of the nation's largest dermatology organizations, as the company looks to apply agentic artificial intelligence to a growing specialty care access problem.
WeChat Zero-Click Worm Took Over Accounts on iPhone and Android via Incoming Calls
A WeChat worm demo took over iPhone and Android accounts through incoming calls from existing contacts; Calif says Tencent blocked the exploit.
MAGA Billionaire’s Ugly Business Baggage Exposed
The revelations come as the midterm race for Georgia heats up on multiple fronts.
Zac Taylor Updates Tee Higgins, Ja'Marr Chase's Health Trajectory Ahead of Week 1 Battle Against Tampa Bay
Trying to make it happen this week.
Five iPhone 18 Pro Camera Features Seemingly Leak in Code
Apple is working on a broader set of Camera app improvements in iOS 27 it has announced, according to a new deep dive from MacRumors forum member "pdfu". iOS 27 beta code apparently points to five features that could arrive alongside new iPhone models this week or in a future software update: Exposure scopes: The Camera app can display a waveform or histogram to help judge exposure while shooting.
Prof Elizabeth Streicher unravels the science behind drug-resistant TB
Prof Elizabeth Streicher of the Division of Molecular Biology and Human Genetics delivered her inaugural lecture on Tuesday 1 September 2026. Her research focuses on the transmission and spread of Tuberculosis (TB). Knowing where TB transmission is happening can help to stop it from spreading. Prof Elizabeth Streicher of the Division of Molecular Biology and Human Genetics in the Faculty of Medicine and Health Sciences delivered her inaugural lecture on Tuesday 1 September 2026. The title of her lecture was Decoding tuberculosis: the evolution of technology, epidemiology and the Mycobacterium tuberculosis genome. Streicher explained to Corporate Communication and Marketing how molecular epidemiology (using genetic information to track how and why diseases spread through populations) has improved our understanding of where drug-resistant TB comes from, how it spreads and how drug resistance evolves within and between populations. Tell us more about your research and why you became interested in this specific field. Overall, our research group studies the genome (complete set of DNA instructions found in a cell) of Mycobacterium tuberculosis, the bacteria that cause tuberculosis (TB) disease. Various regions of the genome are interrogated to study different aspects of the disease. My main focus has been on the epidemiology of tuberculosis – how the bacteria’s genome changes over time and what this tells us about the transmission and spread of the disease. How would you describe the relevance of your work? If we understand how the bacteria that cause TB change and spread, it can assist in combating TB globally. How has molecular epidemiology helped improve our understanding of drug-resistant TB? Molecular epidemiology was very important in drug-resistant TB as it was originally believed that bacteria that become resistant to antibiotics would be less fit and not be able to transmit. But it was shown that they can transmit, and therefore have to be monitored to identify hotspots of transmission and outbreaks, etc. Can you tell us briefly about the spoligotyping technique and its advantages for studying drug-resistant TB? Spoligotyping (a molecular technique used to identify and track specific strains of TB bacteria) does not detect drug resistance, but since the technique is relatively quick to do, it can be very useful in real-time situations, e.g. to monitor outbreaks of drug resistance. Why are interrupting transmission chains and identifying genomic hotspots important for controlling the spread of TB? Knowing where TB transmission is happening can assist in allocating resources to those areas to stop future transmission and spread of TB. Higher education can be challenging. What keeps you motivated when things get tough? Students – how they are so passionate and dedicated to learning and contributing to research and society as a whole. What aspects of your work do you enjoy the most? Again, the students and colleagues! But also the fact that it is continuously changing and thereby we are learning and expanding our knowledge. In the end, I know that we contribute to a better society in our small way. Tell us something exciting about yourself that people would not expect. Even though I love hiking (day and multi-day hikes) and being outside, I really do not like camping! How do you spend your free time? I love hiking (wellbeing in nature) and like to watch most sports. ©Higher Education Media Services. Subscribe
The science behind the beauty business
Some of Europe’s industrial champions may be in retreat, but its cosmetics sector remains a global leader, buoyed by healthy demand, recognised brands and a reputation for innovation."The fact is, the science in cosmetics is better here in Europe than anywhere else in the world,” says Pierre Morvan, CEO of Technature, a private label cosmetics manufacturer located near Brest in France’s northwestern Brittany region. “You have to have good science in order to make the difference, and that is why we invest so much in research and innovation.”Across Europe, the beauty and skincare products sector supports an estimated 3.6 million jobs, including 265,000 employed directly in the industry, according to the Cosmetics Europe trade group.. Cosmetics production contributes an estimated €11 billion to the EU economy, and generated €30 billion in export revenue last year, a €400 million rise from 2024.Technature itself has a global footprint, supplying products for 1,500 brands in 65 countries. Its range of skin gels, facial masks, nail treatments and other products include natural ingredients and extracts derived from plants, such as seaweed, that are developed and refined through science-based analysis and testing.While industry projections point to sustained growth for the foreseeable future, driven by emerging economies and wider availability of exclusive brands that were once chiefly sold by high street retailers, the sector is not immune to the impact of geopolitics and trade wars. The Trump Administration’s tariff threats have dented cosmetics exports to the EU industry's largest overseas market. After the European Parliament approved the EU-US Turnberry Agreement in June, setting a 15% levy on many EU goods, the French Federation of Beauty Companies warned that “exports are falling sharply” and urged the EU to negotiate an opt-out for cosmetics.Technature’s CEO flags South Korea as an emerging competitor, partly due to its assertive marketing efforts. “I would have to say I am a little bit scared,” Morvan says, regarding the growth potential of the South Korean cosmetics industry. “This is why science and innovation are so important if Europe is to remain the leader.”With a workforce of 200, including biologists, chemists and other scientists, around 15% of Technature’s staff work in three research and development (R&D) labs. A similar number work in four quality control and assurance facilities, where science plays a crucial in ensuring product safety in a sector that is subject to the European Cosmetics Regulation.Educational exchange between industry and academiaIn recognition of Technature’s research and innovation, Morvan was selected as one of Brest’s ambassadors to Science Comes to Town (SCTT), a European initiative to strengthen communications and understanding between science and society. Brest is one of three coastal cities in the EU-funded programme, alongside Split (in Croatia) and Kiel (in Germany). From 7-11 September, Brest will host the EU TalentOn contest featuring 100 early-career researchers from across Europe.Morvan appreciates the value of engagement with educational and scientific institutions as well as the home community. For instance, Technature collaborates closely with university partners to enhance its in-house R&D. In addition, it invites students to its labs and sends its own researchers to local institutions. "We absolutely want the students to know what the industry is all about,” Morvan says, noting that seeing science in action can help young people “understand that they can do something real with science, to create something with what they are learning.” He says another important benefit: encouraging new generations of young people to consider a career in cosmetics.Community involvement also raises awareness about Technature and the skincare industry as a whole. “The public gains recognition of the innovative company that we are, and this is important for getting new customers,” Morvan says. One of its recent innovations — tiny, colourful cosmetic pearls that release skin moisturisers on application — was showcased at this year’s VivaTech event in Paris.Morvan holds a master's degree from the Brest Business School and studied animal production and biology in Brest at the University of Western Brittany (UBO), an SCTT partner, and at the University of Tours. He got his start in business in 2002, initially working on using seaweed as a raw material in the food industry before transitioning to cosmetics. Morvan has always been interested in connecting science and business, reflecting one the goals of SCTT to enhance public-private collaboration.The invitation to participate in SCTT was unexpected. “It was a surprise to get a call from the city of Brest saying that they wanted me on this programme,” Morvan recalls, adding that officials were drawn by his company’s R&D. “It's not only theory and science fundamentals. Our science is something that is applicable to the global market — and important for the community.”Science|Business, which connects policymakers, academics and industry through its news reporting, analysis and events, is an SCTT partner.
32 reactions | AfD leader Tino Chrupalla called Germany's extreme...
AfD leader Tino Chrupalla called Germany's extreme summer "perfectly normal" and dismissed concerns as scaremongering. But temperature records — and climate science — tell a different story....
Many truckers don't feel like the rest of America about AI data centers as business booms
Sprawling data center components from HVAC systems to tubing, wiring and semiconductors arrive primarily by truck, a boon for a business hit hard by trade wars.
Top Stories: 'Surprise and Shine' Apple Event Preview, John Ternus Takes Over, and More
After years of rumors, the highly anticipated foldable iPhone is almost here, but that's not all we're expecting to see at next week's big event, and we've got full coverage of expectations for the "Surprise and Shine" event.
Inside the D.O.J.’s Investigation of Fauci and Other Virus Scientists
As Dr. Anthony Fauci has faced public scrutiny from congressional Republicans, the D.O.J. has pursued a quieter and more expansive effort against a wider circle of researchers.
RV business donates temporary living quarters for Cape firefighters
McDowell South RV donates temporary living quarters to Cape Girardeau Fire Station 1 staff.
Johnson scraps House votes before midterms
The move will leave just four days for legislation before the midterms
Greystar Announces BMW Lease at Mid85 Logistics Park Near Spartanburg
Greystar, a global leader in rental housing, investment management, development, and property management, today announced a long-term lease with BMW North America at Mid85, its Class A logistics park in the Greenville-Spartanburg...
Smart ring maker Oura files to go public, pitching investors on AI-driven preventive health
Oura, the smart ring maker and health tracking company, filed to go public on Thursday to fuel its next phase of growth as it aims to build an artificial intelligence-powered health platform. | Oura, the smart ring maker and health tracking company, filed to go public on Thursday to fuel its next phase of growth as it aims to build an artificial intelligence-powered health platform.
Healthcare Dealmakers—UHS closes Talkspace acquisition, Sanford's North Memorial deal clears and more
Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, payers and other industry players look to expand their businesses and gain a competitive edge. | Sword Health nears Headspace all-cash acquisition, HCA Healthcare adds dozens of Texas urgent care centers and more healthcare merger and acquisition news from August.
Weekly Rundown: LeanTaaS acquires care transition platform Aidin; Hims expands to Australia
Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief. Read below for news from the week of Aug. 31 to Sept. 4. | The latest news from Vitality, Icario, LeanTaas, Aidin, Healwell AI and Hims.
Jennifer Aniston shares the life advice her ‘dear friend’ Dolly Parton gave her
The late Dolly Parton was a ‘dear friend’ to Jennifer Aniston, who gave her some sweet — and useful — life advice.
Clay County Sheriff’s Office: Scammer posing as local cop nearly cons business out of cash
The Clay County Sheriff’s Office is warning local businesses to be on high alert after a police impersonator scam nearly cost a local employee her store’s cash.
CMI boosts medical affairs capabilities with new specialty communications unit
CMI Media Group is adding to its spread of media services through a new specialty communications business that introduces a slate of new cutting-edge marketing tools. | The new business unit is centered on four core capabilities, which includes AI-enhanced scientific intelligence, omnichannel "scientific ecosystems," and more.
Rooney and Kate Mara had to speak in unison in 'Bucking Fastard'
Werner Herzog's new film "Bucking Fastard" features sisters Rooney and Kate Mara playing siblings who speak in unison.
AI boom through 2050 hinges on power supply, politics, PwC says
PwC expects global data center capex will hit $31.6 trillion by 2050 in a base case scenario, with spe | AI may unleash a $31.6 trillion data center buildout by 2050, but PwC says the real race isn’t just for capital — it’s for power, chips and political advantages.
AI boom through 2050 hinges on power supply, politics, PwC says
PwC expects global data center capex will hit $31.6 trillion by 2050 in a base case scenario, with spe | AI may unleash a $31.6 trillion data center buildout by 2050, but PwC says the real race isn’t just for capital — it’s for power, chips and political advantages.
Who will be this year's Indiana? 👀 Joel Klatt Show
Joel Klatt examined who will be a dark horse this year and be this year's Indiana.
Mad Science: Soda Can Experiments
Radiant Randy is back in the My KC Live studio to share a few experiments with soda cans.
How New York Times Reporters Traced Dark Money in Politics
About $1 billion in anonymous contributions is coursing through midterm races across the country. Figuring out where the funds are coming from is no easy task.
Fiesta Sports Foundation opens applications for ‘Wishes for Teachers’ grant program
The Fiesta Sports Foundation has opened applications for its 11th annual Wishes for Teachers program, which will award grants to Arizona teachers.
ChatGPT for Healthcare unveils new integrations with Epic, public health data sources
OpenAI is expanding ChatGPT's healthcare capabilities with new integrations that connect it more directly with clinical workflows and public healthcare sources. | OpenAI is expanding ChatGPT's healthcare capabilities with new integrations that connect it more directly with clinical workflows and public healthcare sources.
Bessent downplays bond market concerns amid global sell-off
Bond market investors are growing increasingly nervous as fighting resumes in the Middle East.
Philippines’ richest billionaire agrees to buy African port operator spanning three countries
Enrique Razon-controlled ICTSI has agreed to acquire an African port operator with businesses in South Africa, Mozambique and Namibia
Trump Says Venezuelan Oil Will Refill U.S. Stockpiles, but It’s Not So Simple
New projects can take years to produce meaningful amounts of oil, and that’s especially true in Venezuela, where infrastructure is in disrepair.
Deadline Hollywood
After Jelly Roll avoided discussing his politics at the Grammy Awards in February, he peeled off the band-aid this week with a heartfelt speech. Read more below.
3.2K views · 13 reactions | Our media and politics reporter Ken...
Our media and politics reporter Ken Bensinger examines how political campaigns in the U.S. are increasingly paying social media influencers for support, though the ties are not always clearly...
Player Availability Report: #SKCvVAN
Player Availability Report is SportingKC.com’s look at the latest status updates around the team ahead of upcoming matches and is presented by Saint Luke’s. All details listed are from the league’s official Player Status Report that is submitted the day prior to the match. Sporting Kansas City returns home this
Fitchburg bookseller tries to revitalize downtown
The old mill city has long battled a shaky economy and business closures. Now, it is undergoing its largest makeover yet in the hopes of becoming a destination.
Gender politics obscure tragedy in Clancy trial
Too many on both sides of this toxic debate show minimal awareness of the facts.
Great Lakes Sports & Entertainment Network to air Loons-Lugnuts match Sunday
Fans can tune into the new Great Lakes Sports & Entertainment Network to watch the Loons game on Sunday at 1 p.m.
Democrats at odds in Michigan over El-Sayed’s ties to controversial streamer
Senate nominee Abdul El-Sayed (D) has close political ties to political commentator Hasan Piker, who has been accused of antisemitism. Piker says his comments against Israel have been misunderstood.
Norwegian King Harald's health is in very serious condition, palace says
Norwegian King Harald is in very serious condition as his health deteriorates, according to palace officials
Senator Markey had ‘iPad' moment. Will it help Moulton's age pitch?
Perhaps now more than ever, the nation’s aging political class is once under renewed scrutiny.
Apple's iPhone Event Tagline is Different in Every Country
Apple today announced it will hold its annual iPhone-centric event on Wednesday, September 9 at 10 a.m. Pacific Time. In the U.S. and several other countries, Apple used "Surprise and Shine" as its tagline for the event, but in other countries, the tagline isn't a literal translation. Here are the different taglines Apple is using on its regional websites. U.S., UK, NZ, Australia, Ireland, India - Surprise and Shine.
Sword Health to acquire Headspace in all-cash deal
Virtual physical therapy platform Sword Health is planning to acquire digital mental health company Headspace in an all-cash deal, according to a regulatory filing from the latter. | The virtual physical therapy and mental health platforms are targeting a September close, per a regulatory filing. A price tag was not disclosed, but is being reported to land between $200 million and $300 million.
Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business
This year has seen a growing number of medtechs hit by cyberattacks, and now Boston Scientific has become the latest victim. In an SEC filing posted Aug. 26, the medtech giant said it had detected a “cybersecurity incident” the day before. The incident has affected certain parts of its information technology systems, something that “has resulted in a global disruption to the company’s operations.” The incident has hit not just its information systems but also its business applications, which “support aspects of the Company’s operations,” it said in the filing. This includes its ability to process and ship customer orders. Boston Scientific said it is working to restore the systems, but the timeline remains unknown. Related Baylor Genetics hit by cybersecurity attack targeting patient, staff information As the company investigates the incident, it remains unclear how significantly its business will be affected. “Accordingly, the Company has not yet determined whether the incident is reasonably likely to have a material impact.” The company’s shares were down 3.5% in premarket trading as the news broke. This adds another layer of pressure for the medtech, which last month revealed a new global restructuring program that starts this year and is slated to be completed by 2029. The company said at the time that it “does expect some headcount reductions to result from these restructuring activities,” but did not provide any numbers or specify areas where the cuts may be made. It added, however, that new jobs are also set to be “created in areas of growth.” It was also forced to cut its sales guidance in Q2, saying in late July that it now expects full-year 2026 organic revenue growth of 5% to 6%, down from its previous guidance of 6.5% to 8%. Boston Scientific is one of a growing number of life sciences companies, notably medtechs, that have been hit by cyberattacks this year. These include Abbott, iRhythm, Medtronic and Stryker, as well as Big Pharmas Amgen and Novo Nordisk.
Heroes of Might and Magic III Remake: Return to Erathia in 2027
Remaining faithful to everything that made the original game so beloved, the remake will feature updated visuals and audio for current-gen consoles, a cohesive narrative, and improved UGC features.
Why business owners are suing Zohran Mamdani
The initiative is one of Mamdani's main promises, with its first store expected to open in 2027. But why are some business owners against the move?
Fullspan Health’s AI agent sees strong early traction with 1.1M views since June launch
Fullspan Health’s conversational artificial intelligence agent is gaining traction among users. | The conversational AI tool—dubbed Healthline AI—is sourced directly from the publisher’s medically reviewed properties.
Will data centers be Oregon’s big political issue this fall?
The push to build more of them has brought the subject to the fore, sometimes in unexpected places.
Autonomy and Innovation
Incentives favor offense when it comes to agentic cybersecurity; it’s the same dynamic that will limit incumbents and fuel startups in the long run.
DOE and Princeton University extend, strengthen partnership
The U.S. Department of Energy and Princeton University have signed a five-year extension of the contract for Princeton’s management and operation of the Princeton Plasma Physics Laboratory.
Why environmental performance is becoming a business priority for solid waste
For solid waste operators, environmental performance has always been essential. What’s shifting now is its central place in core business strategy.
IndyCar prez: Freedom 250 Grand Prix of Washington D.C. likely to be a one-off
President Trump’s administration and D.C. Mayor Muriel Bowser are interested in turning the Freedom 250 Grand Prix into an annual event, but it’s currently shaping up to be a one-and-done, according to IndyCar President Doug Boles.
‘Disgusted’: Birmingham home health workers say delayed pay arrives after Local 4 reached out, issue persists
Workers at an in-home health healthcare program based in Birmingham say they went without pay for about a month, with no word on why. They called Local 4 for help. Within hours, cashier’s checks were hand delivered to the employees.
Morning 4: Here are the 80 businesses you voted best in Metro Detroit
Morning 4 is a quick roundup of stories we think you should know about to start your day.
Weekly Rundown: Expressable joins Amazon's health conditions program; Function launches data connector for AI platforms
Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief. This is news from the week of Aug. 17 to 21. | Stay up to date on the latest in health tech, digital health and health AI news with this weekly brief.
Regeneron podcast turns science learnings into immersive experience
Regeneron is showing off its science in a whole new light with its “Science Illuminated” series, a unique vide | Regeneron's "Science Illuminated" podcast series transforms scientific topics into a calming, meditative-style video and audio experience.
Cityblock acquires Homeward Health to move into rural healthcare, lands $116M funding round
Cityblock Health, a company primarily focused on providing care for urban Medicaid and dual-eligible members, is acquiring Homeward Health to expand deep into rural markets, the company announced T | Combined, the two companies will serve nearly 250,000 people and are positioned to reach the120 million people receiving government-funded healthcare in the U.S., Toyin Ajayi, Cityblock Health CEO and co-founder wrote in a blog post.
Resistance 1.0 Was Not Crazy
The much-derided movement was right about Trump’s nature, and how to defeat him.
Apple Card Turns Seven With Big Change Ahead
Today marks the seventh anniversary of the Apple Card becoming widely available in the U.S., following a more limited preview period. Apple's credit card can be managed in the iPhone's Wallet app, with key benefits including color-coded spending summaries, no fees, and Daily Cash cash back paid out daily. Apple Card holders can also open a high-yield savings account. The anniversary comes ahead of a big change planned for the Apple Card.
Special Olympics Florida highlights health screenings for athletes
Program offers free health services in eight disciplines statewide
States pour taxpayer dollars into college sports as athlete pay, soaring costs squeeze budgets
A growing number of states are providing tax dollars to university athletics.
Secret 'messages' in cat pee let felines identify each other — and scientists just cracked the code
Cats can identify each other by the scent of their pee. We now know why.
Cloudflare Workers Spectre Attack Leaks JWT From Co-Located Worker at 12 Bits/Second
Researchers leak a JWT from a co-located Cloudflare Worker via Spectre at up to 12 bits per second; Cloudflare says the attack is mitigated.
MiAsia Symone has the latest in entertainment headlines
The Fast & Furious franchise could be coming to an end, and Tyra Banks speaks out after backlash for her Netflix documentary.
Brantone Veylor Launches Its European Strategic Expansion
NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Brantone Veylor recently announced the launch of a new phase in its European market strategy, identi...
Columbia event to focus on Medicare and mental health coverage
The community was invited to a free conversation about Medicare and mental health Tuesday at the Trinity Educational Community Center.
Akin, an Elite Global Law Firm
Akin energy & infrastructure partner Mitch Holzrichter has been named to Crain’s Chicago Business’ 2026 Notable Leaders in Accounting, Consulting & Law, which recognizes professionals whose work…
Happy Health secures $75M to expand AI-powered care in the home starting with sleep apnea
Digital health company Happy Health secured a $75 million series A funding round to continue building its artificial intelligence-powered platform for continuous home-based care. | The startup’s smart ring—dubbed Happy Ring—was first cleared by the FDA in 2024.
Today's NYT Strands Hints (and Answer) for Tuesday, August 18, 2026
If you’re looking for hints and answers for Tuesday, August 18, 2026 with the theme “Fool me once …,” read on.
Alia Shawkat addresses those Brad Pitt dating rumors 6 years later
‘The Wrong Girls’ actress Alia Shawkat is unpacking those Brad Pitt dating rumors, more than six years after they were spotted together on several occasions: ‘This is my favorite question.’
Microsoft admits Windows 11's context menus are "cluttered and sluggish": Announces major upgrades to the right-click menu that increases performance and customizability
Windows 11's context menus are being overhauled with more customizability and a new decluttered layout that's faster to open.
Apple Releases iOS 26.6.1, macOS 26.6.2, and More
Apple today released iOS 26.6.1, iPadOS 26.6.1, visionOS 26.6.1, and macOS 26.6.2, with all of the updates containing security fixes. Apple also released iOS 18.7.10 and iPadOS 18.7.10 with security fixes. Apple also released iOS 18.7.10 and iPadOS 18.7.10 with security fixes.
Pennsylvania Highlights Housing Investments to Improve Health
Pennsylvania officials have committed $1 million in state funding to connect vulnerable Medicaid recipients with housing and health services. | State funding will bring housing support for Medicaid recipients with chronic health conditions.